CO-1
CO-1 is an IgG4 anti-CD47 antibody. CO-1 not only enhances themacrophage phagocytosis activity but also induces a unique and fast form of programmed celldeath (PCD) in cancer cells directly through ligation of CD47. CO-1 has anticancer activity against hematologic malignancies such as acute lymphoblastic leukemia.
For research use only. We do not sell to patients.
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
IC50 & Target
CD47
In Vitro
CO-1 induces rapid (within 3 hours) and potent (≥40%) programmed cell death in several cell lines derived from hematologic malignancies (Jurkat, MOLT-4 and REH)[1].
CO-1 does not cause hemagglutination of red blood cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Application
ELISA, FACS, Functional assay
Product Details
-
Accession Q08722
-
Species Reactivity
Human
-
Conjugated
Unconjugated
-
Isotype
Human IgG4 kappa
-
Recommend Isotype Controls
Product Properties
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Reconstitution
The product can be reconstituted/diluted with sterile PBS or saline.
-
Storage & Stability
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Keywords
- CO-1
- CO1
- CO 1
- CD47
- Cluster of Differentiation 47
- MER6
- OA3
- CD47-SIRPα interaction
- DEU1
- hematologic malignancies
- programmed cell death
- red blood cells
- xenograft model
- NSG mice
- RBC
- macrophage phagocytosis
- CD47 ligand
- Jurkat
- hematological cancer cells
- cancer cells
- human B cell precursor acute lymphoblastic leukemia
- MalT A
- Inhibitor
- inhibitor
- inhibit